HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIX: Influence of the antithrombotic oligoamine RE 1492 on the storage of red blood cells, morphology, their potassium and ATP content, hemolysis and viability.

Abstract
The influence of RE 1492 on the storage of red blood cells (RBCs) was investigated. RE 1492 (c > or = 50 mumol/L) induces the formation of cup cells and hence delays the appearance of echinocytes and crenated spheres in the blood. A concentration of 50 mumol/L RE 1492 drops hemolysis by 50%. At this concentration after 6 h of storage the potassium efflux was enhanced significantly. The ATP concentration was decreased between 12 h and 24 h of storage. During the first 6 h these alterations have no effect on the in vivo viability of RBCs. After 12 h of storage a significant reduction in viability is observed. We suppose that the changes observed are due to the intercalation of RE 1492 in the phospholipid matrix of the RBC membrane, followed by an accelerated substrate turnover in the RBCs.
AuthorsK Rehse, S Müller
JournalArchiv der Pharmazie (Arch Pharm (Weinheim)) Vol. 328 Issue 4 Pg. 339-42 (Apr 1995) ISSN: 0365-6233 [Print] Germany
PMID7611830 (Publication Type: Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Polyamines
  • RE 1492
  • Adenosine Triphosphate
  • Potassium
Topics
  • Adenosine Triphosphate (blood)
  • Blood Preservation
  • Erythrocyte Membrane (drug effects)
  • Erythrocytes (drug effects, metabolism, ultrastructure)
  • Fibrinolytic Agents (pharmacology)
  • Hemolysis (drug effects)
  • Humans
  • In Vitro Techniques
  • Polyamines (pharmacology)
  • Potassium (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: